Importantly, SSc patients with higher baseline GDF-15 level showed lower DLCO and worsened lung diseases severity score over a follow-up period of up to 30 months, suggesting its value as a predictive prognostic marker of lung function and fibrosis in SSc [65] (Table 5). The gene discussed is GDF15; the disease is systemic sclerosis.